Cambridge, MA. February 14, 2013. Today Immuneering celebrates 5 years in business. Since the company’s founding in early 2008, Immuneering has helped many of the world’s top pharmaceutical and biotechnology companies identify actionable new insights in biological data. Over the years, the company’s MIT-trained team has developed a broad set of proprietary algorithms and methods to find new patterns in gene expression, single-nucleotide polymorphism (SNP), proteomic, and other forms of data and extract biological meaning from these patterns. Immuneering CEO Ben Zeskind marked the occasion, saying “The entire Immuneering team is proud to reach this milestone. We’re constantly working to develop new ways to extract insights from data, and look forward to further growth and an exciting future of helping our pharma and biotech partners maximize the success of their medicines.”
